The Korean journal of internal medicine

  • 제39권1호
  • /
  • Pages.2-3
  • /
  • 2024
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Could histologic healing be a new treatment target in patients with ulcerative colitis?

  • Soyoung Kim (Department of Gastroenterology, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Sang Hyoung Park (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2023.12.06
  • 심사 : 2023.12.10
  • 발행 : 2024.01.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Song EM, Yang SK. Natural history of inflammatory bowel disease: a comparison between the East and the West. Intest Res 2022;20:418-430.  https://doi.org/10.5217/ir.2021.00104
  2. Turner D, Ricciuto A, Lewis A, et al.; International Organization for the Study of IBD. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2021;160:1570-1583.  https://doi.org/10.1053/j.gastro.2020.12.031
  3. Seong G, Song JH, Kim JE, et al. Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with Mayo endoscopic subscore of 0 or 1. Inflamm Bowel Dis 2023;29:238-244.  https://doi.org/10.1093/ibd/izac075
  4. Jangi S, Yoon H, Dulai PS, et al. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Aliment Pharmacol Ther 2020;52:1008-1016.  https://doi.org/10.1111/apt.16026
  5. Shin SY, Kim HS, Kim K, et al. Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity. Korean J Intern Med 2023 Dec 13 [Epub]. DOI:10.3904/kjim.2023.167. 
  6. Bressenot A, Salleron J, Bastien C, Danese S, Boulagnon-Rombi C, Peyrin-Biroulet L. Comparing histological activity indexes in UC. Gut 2015;64:1412-1418.  https://doi.org/10.1136/gutjnl-2014-307477
  7. Korelitz BI. Mucosal healing as an index of colitis activity: back to histological healing for future indices. Inflamm Bowel Dis 2010;16:1628-1630.  https://doi.org/10.1002/ibd.21268
  8. Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol 2014;12:929-934.e2.  https://doi.org/10.1016/j.cgh.2013.07.022
  9. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-1816.  https://doi.org/10.1053/j.gastro.2011.01.057
  10. Ahmad HA, East JE, Panaccione R, et al. Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions. Intest Res 2023;21:283-294. 
  11. Takenaka K, Kawamoto A, Okamoto R, Watanabe M, Ohtsuka K. Artificial intelligence for endoscopy in inflammatory bowel disease. Intest Res 2022;20:165-170. https://doi.org/10.5217/ir.2021.00079